Ruby Bio is a biosynthesis platform that manufactures biodegradable and non-toxic molecules.
Ruby Bio has raised $8.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2025.
Ruby Bio's investors include Alumni Ventures, The Venture Collective, Kicker Ventures.
Ruby Bio is headquartered in Oakland, United States.
Ruby Bio is a biosynthesis platform that manufactures biodegradable and non-toxic molecules.
Ruby Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ruby Bio — Funding & Investors." VCBacked, June 9, 2025, https://www.vcbacked.co/company/ruby-bio. Accessed September 29, 2026.
VCBacked. (2025). Ruby Bio — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/ruby-bio
{{cite web |title=Ruby Bio — Funding & Investors |url=https://www.vcbacked.co/company/ruby-bio |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated